These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 20531019)

  • 1. Familial resemblance of bone mineral density in children with inflammatory bowel disease.
    Schmidt S; Mellström D; Norjavaara E; Sundh V; Saalman R
    J Pediatr Gastroenterol Nutr; 2010 Aug; 51(2):146-50. PubMed ID: 20531019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bone metabolism in 53 children and adolescents with chronic inflammatory bowel disease].
    Scheer K; Kratzsch J; Deutscher J; Gelbrich G; Borte G; Kiess W
    Klin Padiatr; 2004; 216(2):62-6. PubMed ID: 15106075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Osteodensitometry in children and adolescents with inflammatory bowel disease].
    Kluge G; Borte M; Richter T; Kahn T; Borte G
    Rofo; 2007 Jan; 179(1):58-64. PubMed ID: 17203445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.
    ; ; Bousvaros A; Antonioli DA; Colletti RB; Dubinsky MC; Glickman JN; Gold BD; Griffiths AM; Jevon GP; Higuchi LM; Hyams JS; Kirschner BS; Kugathasan S; Baldassano RN; Russo PA
    J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Femoral neck osteopenia in patients with inflammatory bowel disease.
    Pollak RD; Karmeli F; Eliakim R; Ackerman Z; Tabb K; Rachmilewitz D
    Am J Gastroenterol; 1998 Sep; 93(9):1483-90. PubMed ID: 9732930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased urinary N-telopeptide cross-linked type 1 collagen predicts bone loss in patients with inflammatory bowel disease.
    Dresner-Pollak R; Karmeli F; Eliakim R; Ackerman Z; Rachmilewitz D
    Am J Gastroenterol; 2000 Mar; 95(3):699-704. PubMed ID: 10710060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A decision tree-based approach for determining low bone mineral density in inflammatory bowel disease using WEKA software.
    Firouzi F; Rashidi M; Hashemi S; Kangavari M; Bahari A; Daryani NE; Emam MM; Naderi N; Shalmani HM; Farnood A; Zali M
    Eur J Gastroenterol Hepatol; 2007 Dec; 19(12):1075-81. PubMed ID: 17998832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of esophagogastroduodenoscopy in the initial assessment of children with inflammatory bowel disease.
    Lemberg DA; Clarkson CM; Bohane TD; Day AS
    J Gastroenterol Hepatol; 2005 Nov; 20(11):1696-700. PubMed ID: 16246188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association of MYO9B gene in Italian patients with inflammatory bowel diseases.
    Latiano A; Palmieri O; Valvano MR; D'Incà R; Caprilli R; Cucchiara S; Sturniolo GC; Bossa F; Andriulli A; Annese V
    Aliment Pharmacol Ther; 2008 Feb; 27(3):241-8. PubMed ID: 17944996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bone loss owing to inflammatory bowel disease: prospective study, 50 cases].
    Ben Hamida KS; Serghini M; Ksontini I; Kedadi H; Ben Yaghléne L; Bougassas W; Dougui MH
    Tunis Med; 2009 Feb; 87(2):144-8. PubMed ID: 19522449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered bone metabolism in inflammatory bowel disease.
    Bischoff SC; Herrmann A; Göke M; Manns MP; von zur Mühlen A; Brabant G
    Am J Gastroenterol; 1997 Jul; 92(7):1157-63. PubMed ID: 9219790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pathological bone density in chronic inflammatory bowel diseases--prevalence and risk factors].
    Von Tirpitz C; Pischulti G; Klaus J; Rieber A; Brückel J; Böhm BO; Adler G; Reinshagen M
    Z Gastroenterol; 1999 Jan; 37(1):5-12. PubMed ID: 10091278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
    Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
    Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The incidence of inflammatory bowel disease in a rural region of Southern Germany: a prospective population-based study.
    Ott C; Obermeier F; Thieler S; Kemptner D; Bauer A; Schölmerich J; Rogler G; Timmer A
    Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):917-23. PubMed ID: 18794607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High prevalence of morphometric vertebral deformities in patients with inflammatory bowel disease.
    Heijckmann AC; Huijberts MS; Schoon EJ; Geusens P; de Vries J; Menheere PP; van der Veer E; Wolffenbuttel BH; Stockbrugger RW; Dumitrescu B; Nieuwenhuijzen Kruseman AC
    Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):740-7. PubMed ID: 18617778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Passive smoking is associated with an increased risk of developing inflammatory bowel disease in children.
    Lashner BA; Shaheen NJ; Hanauer SB; Kirschner BS
    Am J Gastroenterol; 1993 Mar; 88(3):356-9. PubMed ID: 8438840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemokine production by buccal epithelium as a distinctive feature of pediatric Crohn disease.
    Damen GM; Hol J; de Ruiter L; Bouquet J; Sinaasappel M; van der Woude J; Laman JD; Hop WC; Büller HA; Escher JC; Nieuwenhuis EE
    J Pediatr Gastroenterol Nutr; 2006 Feb; 42(2):142-9. PubMed ID: 16456405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased bone density in inflammatory bowel disease is related to corticosteroid use and not disease diagnosis.
    Bernstein CN; Seeger LL; Sayre JW; Anton PA; Artinian L; Shanahan F
    J Bone Miner Res; 1995 Feb; 10(2):250-6. PubMed ID: 7754804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of a CXCL9 polymorphism with pediatric Crohn's disease.
    Lacher M; Kappler R; Berkholz S; Baurecht H; von Schweinitz D; Koletzko S
    Biochem Biophys Res Commun; 2007 Nov; 363(3):701-7. PubMed ID: 17892861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of organic cation transporter risk haplotype with perianal penetrating Crohn's disease but not with susceptibility to IBD.
    Vermeire S; Pierik M; Hlavaty T; Claessens G; van Schuerbeeck N; Joossens S; Ferrante M; Henckaerts L; Bueno de Mesquita M; Vlietinck R; Rutgeerts P
    Gastroenterology; 2005 Dec; 129(6):1845-53. PubMed ID: 16344053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.